Scientific and medical advances in rare diseases continue to accelerate — but equitable access to diagnosis, treatment, and care remains out of reach for millions of people living with a […]
Read MoreMedical devices for rare diseases are becoming increasingly important as healthcare innovation expands beyond orphan drugs and biologics. Emerging technologies such as digital remote monitoring systems are creating new opportunities […]
Read MoreThe Foundation for Rare Diseases has developed a series of three online courses with European and international partners to better understand innovative therapies, health data, and translational research in the […]
Read MoreWe are pleased to share a new publication produced by the IRDiRC Functional Analysis Task Force, highlighting the growing impact of multi-omics in advancing rare disease research and precision medicine. […]
Read MoreUndiagnosed Day 2026 is a two‑day, clinician‑led meeting in Gdansk (Poland) bringing together specialist clinicians, clinical geneticists and invited experts to support phenotype‑led diagnosis through live case discussion, shared clinical […]
Read MoreIRDiRC Patient Advocates Constituent Committee (PACC) member, Genetic Alliance, is pleased to announce that 9 new clinical sites and 1 new laboratory joined the iHope program network, further strengthening the […]
Read MoreThe landscape of medical research is shifting: rare disease patient advocates are no longer just participants, they are the architects of discovery. Driven by an urgent need for life-saving treatments, […]
Read MoreThe third Hope for Rare Science Conference will be held in Shanghai, China from June 25th to 27th, 2026. The conference is hosted by Hope for Rare Foundation, with National […]
Read MoreThe European Rare Disease Research Alliance (ERDERA) has re-opened its survey to better understand where the rare disease research community most needs external consultancy support with the goal to turn […]
Read MoreThe CSNK2A1 Foundation Pilot Grant Program, developed in collaboration with the Orphan Disease Center University of Pennsylvania, member of the IRDiRC Funders Constituent Committee (FCC), will support one investigator-initiated research […]
Read More